[The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples